Clinical evidence dossier
Curcumin supplementation
Malondialdehyde (MDA)
Evidence signal
Authoritative evidence signal
strong
This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.
Evidence snapshot
- Authoritative support records
- 3
- Supporting studies available for review
- 3
- Randomized trials
- 3
- Reported effects
- 7
Clinical conclusion
Curcumin supplementation shows a strong positive evidence signal for improving Malondialdehyde (MDA) across the studied comparisons.
Observed effects
Evidence composition
- Non-randomized studies
- 0
- Other designs
- 0
- Unresolved designs
- 0
- Magnitude-eligible effects
- 0
Consistency
Authoritative consistency classification
consistent
- Positive
- 3
- No effect
- 0
- Mixed
- 0
- Negative
- 0
Population and applicability
Structured population data were available for 3 of 3 supporting studies. 2 studies described participants with type 2 diabetes. 2 studies described adult participants.
This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.
View reported population descriptions
These descriptions are reported across the supporting studies; they are not a single synthesized population.
- Adults diagnosed with metabolic dysfunction-associated steatotic liver disease.
- Patients experiencing elevated inflammatory markers related to liver health.
- Obese patients diagnosed with type 2 diabetes.
- Individuals seeking alternative treatments for liver health.
- Adults aged 18 and older with type 2 diabetes.
- Individuals seeking alternative methods to manage blood sugar levels.
Limitations
- 1 supporting study has high, serious, critical, unclear, or unavailable risk-of-bias information.
- 1 study contains conflicting p-value and significance fields; those significance claims are suppressed.
Supporting evidence
Inspect the authoritative studies and omitted support records for this dossier.